Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/SYNLOGIC INC/ 10-Q

Quarterly Report · 10-Q

SYNLOGIC INC

Quarterly Report

Filed Nov 13, 2025Accepted Nov 13, 2025, 4:30 PM ESTCIK 1527599Accession 0001193125-25-280270
View company →Permanent SEC source ↗
Share

Company context

Synlogic is a biopharmaceutical company historically focused on advancing novel therapeutics to transform the care of serious disease in need of new treatment options.

Current securities

SYBXOTC · EQUITY · Current
Historical securities (2)
SYBXNASDAQ · EQUITY · Historical · closed Jan 20, 2026SYBXOTC · EQUITY · Historical · closed Oct 23, 2026

Recent company filings

  1. 425 filingNov 5, 2026
  2. 425 filingNov 2, 2026
  3. 10-Q filingAug 11, 2026
  4. SCHEDULE 13D/A - filed by New Enterprise Associates 14, L.P. regarding SYNLOGIC, INC.Jul 29, 2026
  5. SCHEDULE 13D/A - filed by Funicular Funds, LP regarding SYNLOGIC, INC.Jul 29, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.